New research suggests that factors like age, sex, body fat and the amount of sugar in your blood play a significant role in the progression from pre-diabetes to a type 2 diabetes diagnosis.

Research identifies key factors affecting semaglutide initiation among obese individuals without diabetes, revealing ...

A group of 58 researchers is calling for a new, better way to measure obesity and excess body fat that goes beyond BMI.

A report from The Lancet Diabetes & Endocrinology Commission has proposed new criteria for defining and diagnosing obesity, ...

“That’s why,” says Dr Naval Vikram Kishore, professor of medicine, Metabolic Research Group, AIIMS, “obesity has to be ...

An international team of doctors proposed a new way to define obesity that's not based solely on BMI. Here's what they ...

An international commission made the case for focusing on body fat quantity and the illnesses people experience.

Obesity and type 2 diabetes are closely linked. Excess body fat can alter your body’s metabolic system, promote insulin resistance, and trigger inflammatory responses that affect how well your ...

A Medscape survey found that a strong majority of physicians believe high-risk patients should have easier access to new weight loss drugs.

Adults with overweight or obesity and type 2 diabetes who are given the sodium glucose cotransporter 2 (SGLT-2) inhibitor drug dapagliflozin alongside moderate calorie restriction achieve much higher ...

The team categorized pediatric obesity treatment response, based on changes in body mass index standard deviation score, as ...

Sociodemographic, health care, and clinical factors are associated with receipt of semaglutide in those with obesity but without diabetes, according to a study published online Jan. 21 in JAMA Network ...